Eone Diagnomics Genome Center Co., Ltd.

245620 KRX Industrials Industrials
KOSDAQ
₩0.00
+0.00%
Delayed · cached 15 min

Fair value analysis

245620
Eone Diagnomics Genome Center Co., Ltd.
IndustrialsIndustrials
₩2,489.50
Close used for this calculation
₩1,706.05Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
42/100
Profitability12/25
Returns3/25
Balance Sheet17/25
Efficiency10/25
Growth0/25
Average
Quality radar
42Prof.12/25Ret.3/25Eff.10/25B.Sht17/25Growth0/25

Consensus fair value

₩1,706.05
Above FV
▼ -31.5% against the close used
Model range ₩469.48 – ₩4,080.00
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩469.48Fair value₩1,706.05Bull₩4,080.00
FairClose
52-week traded range
52W low ₩415.0052W high ₩2,489.50

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Eone Diagnomics Genome Center Co., Ltd. closed at ₩2,489.50, 45.9% above the consensus fair value of ₩1,706.05 drawn from 4 valuation models.

Financial DNA score 42/100 — Average. P/E of 12.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩469.48
-81.1%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
P/E Fair Value
₩4,080.00
+63.9%
EPS × 20x (sector P/E)
EPS=204, Sector P/E=20x
Reverse DCF
₩2,489.50
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 0.4% | Historical: 0%
Margin of Safety
₩1,706.05
-31.5%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=2274.74, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.